Nexstim Plc: Health Canada grants Nexstim NBT® Medical Device License for Canada

- 05/12/2019

Helsinki, Finland: 5 December 2019 – Nexstim Plc (NXTMH:HEX, NXTMS:STO) announces that its NBT® System with SmartFocus® TMS technology has received a medical device license from Health Canada.

The medical device license allows Nexstim to start marketing and commercial distribution of the NBT® system for the treatment of Major Depressive Disorder (MDD) in Canada.

More info on Nexstim‘s website.